Gallic acid suppresses lipopolysaccharide-induced nuclear factor-κB signaling by preventing RelA acetylation in A549 lung cancer cells

Molecular Cancer Research

Volumn 7, Issue 12, 2009, Pages 2011-2021

  Choi, Kyung Chul ^a,b   Lee, Yoo Hyun ^c   Jung, Myung Gu ^a,b   Kwon, Seung Hyun ^b   Kim, Mi Jeong ^a,b   Jun, Woo Jin ^d   Lee, Jeongmin ^e   Lee, Jae Myun ^b   Yoon, Ho Geun ^a,b  

^a Center for Chronic Metabolic Disease Research   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Suwon University   (South Korea)

^d Chonnam National University   (South Korea)

^e Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIC ACID; GAMMA INTERFERON; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE METHYLTRANSFERASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SIRTUIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; ENZYME KINETICS; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LUNG CANCER; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; ROSA RUGOSA; ROSE; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

ACETYLATION; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; E1A-ASSOCIATED P300 PROTEIN; ENZYME INHIBITORS; GALLIC ACID; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; ROSACEAE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

ROSA RUGOSA;

EID: 73849102273     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0239     Document Type: Article

References (38)

1. Ng TB, He JS, Niu SM, et al. A gallic acid derivative and polysaccharides with antioxidative activity from rose (Rosa rugosa) flowers. J Pharm Pharmacol 2004;56:537-45.
2. Kroes BH, van den Berg AJ, Quarles van Ufford HC, van Dijk H, Labadie RP. Anti-inflammatory activity of gallic acid. Planta Med 1992;58:499-504.
3. Pellegrina CD, Padovani G, Mainente F, et al. Anti-tumour potential of a gallic acid-containing phenolic fraction from Oenothera biennis. Cancer Lett 2005;226:17-25.
4. Hsu CL, Lo WH, Yen GC. Gallic acid induces apoptosis in 3T3-1 pre-adipocytes via a Fas- and mitochondrial-mediated pathway. J Agric Food Chem 2007;55:7359-65.
5. Inoue M, Suzuki R, Sakaguchi N, et al. Selective induction of cell death in cancer cells by gallic acid. Biol Pharm Bull 1995;18:1526-30.
6. Li L, Ng TB, Gao W, et al. Antioxidant activity of gallic acid from rose flowers in senescence accelerated mice. Life Sci 2005;77:230-40.
7. Glozak MA, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005;363:15-23.
8. Asano Y, Czuwara J, Trojanowska M. Transforming growth factor-β regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding proteinassociated factor-dependent acetylation. J Biol Chem 2007;282:34672-83.
9. Zeng L, Zhang Q, Gerona-Navarro G, Moshkina N, Zhou MM. Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. Structure 2008;16:643-52.
10. Chen LF, Mu Y, Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J 2002;21:6539-48.
11. Kiernan R, Bres V, Ng RW, et al. Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J Biol Chem 2003;278:2758-66.
12. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004;18:2195-224.
13. Shishodia S, Aggarwal BB. Nuclear factor-κB activation: a question of life or death. J Biochem Mol Biol 2002;35:28-40.
14. Cao Y, Karin M. NF-κB in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2003;8:215-23.
15. Lin A, Karin M. NF-κB in cancer: a marked target. Semin Cancer Biol 2003;13:107-14.
16. Perkins ND. The Rel/NF-κB family: friend and foe. Trends Biochem Sci 2000;25:434-40.
17. Pande V, Ramos MJ. NF-κB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr Med Chem 2005;12:357-74.
18. Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006;5:769-84.
19. Duvic M, Vu J. Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opin Investig Drugs 2007;16:1111-20.
20. Balasubramanyam K, Altaf M, Varier RA, et al. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 2004;279:33716-26.
21. Balasubramanyam K, Varier RA, Altaf M, et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase- dependent chromatin transcription. J Biol Chem 2004;279:51163-71.
22. Sun Y, Jiang X, Chen S, Price BD. Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett 2006;580:4353-6.
23. Lee YH, Jung MG, Kang HB, et al. Effect of anti-histone acetyltransferase activity from Rosa rugosa Thunb. (Rosaceae) extracts on androgen receptormediated transcriptional regulation. J Ethnopharmacol 2008;118:412-7.
24. Madlener S, Illmer C, Horvath Z, et al. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett 2007;245:156-62.
25. Jagan S, Ramakrishnan G, Anandakumar P, Kamaraj S, Devaki T. Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepato-cellular carcinoma. Mol Cell Biochem 2008;319:51-9.
26. Chen LF, Williams SA, Mu Y, et al. NF-κB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 2005;25:7966-75.
27. Serrano A, Palacios C, Roy G, et al. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch Biochem Biophys 1998;350:49-54.
28. Ohno Y, Fukuda K, Takemura G, et al. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999;10:845-51.
29. Faried A, Kurnia D, Faried LS, et al. Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol 2007;30:605-13.
30. Raina K, Rajamanickam S, Deep G, Singh M, Agarwal R, Agarwal C. Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice. Mol Cancer Ther 2008;7:1258-67.
31. Togi S, Kamitani S, Kawakami S, et al. HDAD3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A. Biochem Biophys Res Commun 2009;379:616-20.
32. Levy L, Wei Y, Labalette C, et al. Acetylation of β-catenin by p300 regulates β-catenin-Tcf4 interaction. Mol Cell Biol 2004;24:3404-14.
33. Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T. Acetylation of β-catenin by CREB-binding protein (CBP). J Biol Chem 2002;277:25562-7.
34. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006;124:823-35.
35. Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell 2003;12:723-34.
36. Yoon HG, Chan DW, Huang ZQ, et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J 2003;22:1336-46.
37. Yoon HG, Choi Y, Cole PA, Wong J. Reading and function of a histone code involved in targeting corepressor complexes for repression. Mol Cell Biol 2005;25:324-35.
38. Choi KC, Lee YS, Lim S, et al. Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 2006;7:1057-65.